These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 9256325

  • 21. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.
    Schmid HP, Ravery V, Billebaud T, Toublanc M, Boccon-Gibod LA, Hermieu JF, Delmas V, Boccon-Gibod L.
    Urology; 1996 May; 47(5):699-703. PubMed ID: 8650868
    [Abstract] [Full Text] [Related]

  • 22. Early detection of prostate cancer in the ESRD population.
    Khairullah QT, Pamatmat SD, Chatha M, Provenzano R, Telang D, Temple M.
    Clin Nephrol; 2004 May; 61(5):308-15. PubMed ID: 15182125
    [Abstract] [Full Text] [Related]

  • 23. [Role of ultrasonography-guided prostatic biopsy of hypoechoic areas associated with systematic biopsies in patients with normal and high PSA levels].
    Scattoni V, Roscigno M, Raber M, Consonni P, Freschi M, Montorsi F, Pasta A, Colombo R, Nava L, Bua L, Rigatti P.
    Arch Ital Urol Androl; 2002 Dec; 74(4):273-5. PubMed ID: 12508749
    [Abstract] [Full Text] [Related]

  • 24. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
    Rahardjo D, Kamil ST, Pakasi LS.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
    [Abstract] [Full Text] [Related]

  • 25. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
    Clark TW, Goldenberg L, Cooperberg PL, Wong AD, Singer J.
    Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
    [Abstract] [Full Text] [Related]

  • 26. Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Littrup PJ, Kane RA, Mettlin CJ, Murphy GP, Lee F, Toi A, Badalament R, Babaian R.
    Cancer; 1994 Dec 15; 74(12):3146-58. PubMed ID: 7526969
    [Abstract] [Full Text] [Related]

  • 27. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR, Evans WP, Borden JD, Castellanos RD.
    Cancer; 1994 Dec 01; 74(11):2991-5. PubMed ID: 7525040
    [Abstract] [Full Text] [Related]

  • 28. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T, Kawahara T, Nishizawa K, Ogura K, Mitsumori K, Ide Y.
    BJU Int; 2005 Jun 01; 95(9):1245-8. PubMed ID: 15892809
    [Abstract] [Full Text] [Related]

  • 29. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L.
    Dan Med J; 2017 Feb 01; 64(2):. PubMed ID: 28157066
    [Abstract] [Full Text] [Related]

  • 30. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I, Ruiz Rubio JL, Llorente Abarca C, Aramburu González JA, Montes Díaz MJ, Herrero Payo A, Sánchez Sánchez E, Berenguer Sánchez A.
    Arch Esp Urol; 1995 Feb 01; 48(6):587-94. PubMed ID: 7544968
    [Abstract] [Full Text] [Related]

  • 31. [Utility of prostate specific antigen (PSA) density in detecting prostate cancer in men showing gray zone serum PSA levels].
    Kihara T, Ito F, Kobayashi C, Ryoji O, Tokumoto T, Iguchi Y, Maeda Y, Onizuka S, Goya N, Nakazawa H, Toma H.
    Hinyokika Kiyo; 1997 Jan 01; 43(1):13-8. PubMed ID: 9046415
    [Abstract] [Full Text] [Related]

  • 32. [Role of prostate fossa ultrasonography in the diagnosis of local recurrence after radical prostatectomy in case of PSA failure].
    Roscigno M, Scattoni V, Raber M, Consonni P, Montorsi F, Pasta A, Bertini R, Colombo R, Da Pozzo L, Freschi M, Rigatti P.
    Arch Ital Urol Androl; 2002 Dec 01; 74(4):304-8. PubMed ID: 12508759
    [Abstract] [Full Text] [Related]

  • 33. Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels.
    Dinçel C, Caşkurlu T, Taşçi AI, Cek M, Sevin G, Fazlioğlu A.
    Int Urol Nephrol; 1999 Dec 01; 31(4):497-509. PubMed ID: 10668945
    [Abstract] [Full Text] [Related]

  • 34. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT, Schieda N, El Hallani S, Breau RH, Morash C, Robertson SJ, Mai KT, Belanger EC, Flood TA.
    Virchows Arch; 2015 Oct 01; 467(4):437-42. PubMed ID: 26229020
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Comparison of prostate volume measured by transrectal and abdominal echography and its implication for the measurement of the PSA density for the diagnosis of prostate cancer].
    Rodríguez-Patrón Rodríguez R, Mayayo Dehesa T, Lennie Zucharino A, González Galán A.
    Arch Esp Urol; 2002 Sep 01; 55(7):797-806. PubMed ID: 12380308
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions.
    Cornud F, Belin X, Piron D, Chrétien Y, Flam T, Casanova JM, Hélénon O, Méjean A, Thiounn N, Moreau JF.
    Urology; 1997 May 01; 49(5):709-15. PubMed ID: 9145975
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.